April 5, 2024

The Supreme Court is currently hearing a case between Alliance for Hippocratic Medicine (AHM) and the Food and Drug Administration (FDA), in which the group of pro-life doctors is arguing that the FDA’s approval of the abortion drug mifepristone was “arbitrary and capricious” and puts pro-life medical professionals in a position of completing elective abortions, violating their moral and ethical standards.

In 2000, the FDA approved mifepristone, the first of a two-drug protocol used to kill babies through the 10th week of pregnancy, as a “safe and effective” means of abortion. But in their fervor to provide an “easy,” non-surgical option for abortion, did they bypass serious safety concerns that put women at risk?